Acurx Pharmaceuticals, Inc. (ACXP)

NASDAQ: ACXP · Real-Time Price · USD

1.135

-0.005 (-0.44%)

At close: Oct 23, 2026, 4:00 PM EDT

1.101

-0.034 (-2.96%)

After-hours: Oct 23, 2026, 7:30 PM EDT

Acurx Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	10.66	7.56	3.71	7.47	9.11	12.96
Cash & Short-Term Investments	10.66	7.56	3.71	7.47	9.11	12.96
Cash Growth	75.73%	103.85%	-50.41%	-17.97%	-29.69%	308.10%
Other Receivables	0.1	0.05	0.05	0.13	-	-
Receivables	0.1	0.05	0.05	0.13	-	-
Prepaid Expenses	0.23	0.09	0.1	0.11	0.26	0.3
Total Current Assets	10.98	7.69	3.86	7.71	9.38	13.25
Total Assets	10.98	7.69	3.86	7.71	9.38	13.25

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	0	0.01	0	0	0.03	0.06
Accrued Expenses	2.83	2.41	3.24	3.04	2.03	0.78
Total Current Liabilities	2.83	2.42	3.24	3.04	2.06	0.84
Total Liabilities	2.83	2.42	3.24	3.04	2.06	0.84

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0	0	0	0.01	0.01	0.01
Additional Paid-In Capital	87.37	80.55	67.94	57.87	45.94	38.95
Retained Earnings	-79.22	-75.29	-67.32	-53.22	-38.64	-26.55
Shareholders' Equity	8.15	5.27	0.62	4.67	7.32	12.41
Total Liabilities & Equity	10.98	7.69	3.86	7.71	9.38	13.25

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Cash (Debt)	10.66	7.56	3.71	7.47	9.11	12.96
Net Cash Growth	75.73%	103.85%	-50.41%	-17.97%	-29.69%	316.83%
Net Cash Per Share	3.95	5.04	4.59	11.80	16.85	30.36
Filing Date Shares Outstanding	5.27	2.86	1.1	0.79	0.58	0.51
Total Common Shares Outstanding	4.68	2.35	0.85	0.72	0.58	0.51
Working Capital	8.15	5.27	0.62	4.67	7.32	12.41
Book Value Per Share	1.74	2.24	0.72	6.45	12.58	24.30
Tangible Book Value	8.15	5.27	0.62	4.67	7.32	12.41
Tangible Book Value Per Share	1.74	2.24	0.72	6.45	12.58	24.30

SEC Filings: 10-K · 10-Q